Aurobindo Pharma reported INR982.1M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Cipla INR 170.3M 39M Jun/2026
Divis Laboratories Ltd INR 60M 0 Jun/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Hindustan Unilever INR 760M 120M Mar/2026
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
UPL INR 8.36B 620M Mar/2026